A Non-Interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended-Release Tablets (SEROQUEL XRa) in Subjects With Schizophrenia-An Observational, Multicentric Prospective Study.
Phase of Trial: Phase IV
Latest Information Update: 13 Mar 2010
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms CLIMAX
- Sponsors AstraZeneca
- 13 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Mar 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 13 Mar 2010 Actual patient number (1494) added as reported by ClinicalTrials.gov.